Anticancer Drug Development
Latest Publications

TOTAL DOCUMENTS

25
(FIVE YEARS 0)

H-INDEX

3
(FIVE YEARS 0)

Published By Elsevier

9780120726516
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

RELEVANCE OF PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TO PHASE I TRIAL EXTRAPOLATION TECHNIQUES: RELEVANCE OF ANIMAL TOXICOLOGY

2002 ◽  
pp. 301-328 ◽  
Author(s):  
Joseph E. Tomaszewski ◽  
Adaline C. Smith ◽  
Joseph M. Covey ◽  
Susan J. Donohue ◽  
Julie K. Rhie ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Preclinical Pharmacology ◽  
Pharmacology And Toxicology

DRUG RESISTANCE PATHWAYS AS TARGETS

2002 ◽  
pp. 77-90 ◽  
Author(s):  
Akihiro Tomida ◽  
Takashi Tsuruo
Keyword(s):  
Drug Resistance

GENE-DIRECTED ENZYME PRODRUG THERAPY

2002 ◽  
pp. 137-155 ◽  
Author(s):  
Caroline J. Springer ◽  
Ion Niculescu-Duvaz
Keyword(s):  
Enzyme Prodrug Therapy

GROWTH FACTOR AND SIGNAL TRANSDUCTION TARGETS FOR CANCER THERAPY

2002 ◽  
pp. 31-53
Author(s):  
W.R. Leopold ◽  
Alex Bridges ◽  
Stuart Decker ◽  
David W. Fry ◽  
Alan Kraker ◽  
...  
Keyword(s):  
Signal Transduction ◽  
Growth Factor ◽  
Cancer Therapy

CELL DEATH PATHWAYS AS TARGETS FOR ANTICANCER DRUGS

2002 ◽  
pp. 55-76 ◽  
Author(s):  
Eric Solary ◽  
Nathalie Droin ◽  
Olivier Sordet ◽  
Cédric Rebe ◽  
Rodolphe Filomenko ◽  
...  
Keyword(s):  
Cell Death ◽  
Anticancer Drugs ◽  
Cell Death Pathways
Load More ...
Sign in / Sign up

Export Citation Format

Share Document